CINCINNATI (WKRC) - A groundbreaking study suggests that high doses of vitamin C, when combined with standard chemotherapy, may significantly extend the life expectancy of patients with advanced ...
Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic ...
Medical researchers at the University of Iowa report promising progress in fighting one of the worst cancer killers. The phase-two clinical trial found that adding high-dose, intravenous vitamin C to ...
Survival outcomes in pancreatic cancer: A single-center retrospective study in a large healthcare system. Impact of palliative care on the management and outcomes of elderly pancreatic cancer patients ...
Dr. Joseph Cullen is the lead author on a recently-published University of Iowa study which found that high doses of vitamin C, administered through an IV, increase survival rates and decrease ...
Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic ...
Research shows that vitamin C, particularly in high doses, does not cure cancer. However, investigations into high-dose ...
Pancreatic cancer is a very challenging disease. It’s tough to catch early, spreads rapidly, and doesn’t respond easily to treatment. This year, pancreatic cancer is expected to be the 12th most ...
However, insights from the biomarkers in patients with pancreatic cancer (BIOPAC) study (NCT03311776) showed that higher levels of the inflammatory biomarkers interleukin (IL)-6, YKL-40, and C ...
While some risk factors for cancer can be mitigated through lifestyle choices such as diet or exercise, aging is not one of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback